Comparison of baseline characteristics and outcomes of on-label full dose (20mg) and off-label reduced dose (15mg) rivaroxaban in patients with atrial fibrillation in Asian elderly patients
Event: ESC Congress 2023
Topic: Anticoagulants
Session: Oral anticoagulation in patients with atrial fibrillation
